Compare
Avai Bio, Inc. vs KwikClick, Inc. vs BioScience Health Innovations, Inc. vs Versus Systems Inc.
| Latest fiscal year | Avai Bio, Inc. AVAI | KwikClick, Inc. KWIK | BioScience Health Innovations, Inc. BHIC | Versus Systems Inc. VS |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $1.29M | $5.69M | $2.18M |
| Revenue growth (YoY) | n/a | +718.1% | +208.3% | n/m |
| Gross margin | n/a | n/a | 57.0% | 99.2% |
| Operating margin | n/a | -93.2% | 12.6% | -99.0% |
| Net margin | n/a | -102.3% | 11.3% | -82.1% |
| Net income | -$1.75M | -$1.32M | $642.1K | -$1.79M |
| EPS (Diluted) | n/a | -$0.34 | $0.06 | -$0.37 |
| Operating cash flow | -$1.01M | -$202.1K | $172.2K | -$2.05M |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | $23.1K | $106.5K | $661.9K | $527.4K |
| Total assets | $572.7K | $868.8K | $1.71M | $2.06M |
| Total liabilities | $3.39M | $4.08M | $229.9K | $142.8K |
| Shareholders' equity | -$2.82M | -$3.21M | $1.48M | $10.19M |
| Return on year-end equity | n/a | n/a | 43.5% | -17.6% |
| Shares outstanding | 153.21M | 3.89M | 10.98M | 4.90M |
Revenue, most recent five fiscal years
| Fiscal year | Avai Bio, Inc. | KwikClick, Inc. | BioScience Health Innovations, Inc. | Versus Systems Inc. |
|---|---|---|---|---|
| Latest | $276.3K Ended 2023-03-31 | $1.29M Ended 2025-12-31 | $5.69M Ended 2025-12-31 | $2.18M Ended 2025-12-31 |
| 1 year earlier | n/a | $157.4K Ended 2024-12-31 | $1.84M Ended 2024-12-31 | $57.3K Ended 2024-12-31 |
| 2 years earlier | n/a | $288.2K Ended 2023-12-31 | $597.6K Ended 2023-12-31 | $271.2K Ended 2023-12-31 |
| 3 years earlier | n/a | $606.8K Ended 2022-12-31 | $69.3K Ended 2022-12-31 | $1.11M Ended 2022-12-31 |
| 4 years earlier | n/a | $175.6K Ended 2021-12-31 | n/a | n/a |